The National Healthcare Security Administration (NHSA) has reported that 12 device manufacturers, both domestic and international, have revised the pricing of their thoracic aortic stent graft products. Among these companies are the US-Irish firm Medtronic (NYSE: MDT), Shanghai-based MicroPort Endovascular MedTech Co., Ltd (SHA: 688016), W. L. Gore & Associates, and Lifetech Scientific Corporation (HKG: 1302).
Medtronic has set the average price for its range of thoracic aortic stent graft systems to a maximum of RMB 59,614. MicroPort Endovascular MedTech has adjusted the prices for its Castor branch aortic stent graft and delivery systems, with the 60-190mm model and the 200-210mm model not exceeding RMB 69,563 and RMB 71,500, respectively. In a notable development last week, Endovascular MedTech was queried by the NHSA regarding the pricing of this product, leading the company to pledge a price adjustment.
For further details on this development, please refer to the NHSA’s official statement.- Flcube.com
